HUP0301130A2 - Electrospun pharmaceutical compositions - Google Patents

Electrospun pharmaceutical compositions

Info

Publication number
HUP0301130A2
HUP0301130A2 HU0301130A HUP0301130A HUP0301130A2 HU P0301130 A2 HUP0301130 A2 HU P0301130A2 HU 0301130 A HU0301130 A HU 0301130A HU P0301130 A HUP0301130 A HU P0301130A HU P0301130 A2 HUP0301130 A2 HU P0301130A2
Authority
HU
Hungary
Prior art keywords
pharmaceutical compositions
pharmaceutically acceptable
water
electrospun
electrospun pharmaceutical
Prior art date
Application number
HU0301130A
Other languages
Hungarian (hu)
Inventor
John M. Baldoni
Francis Ignatious
Original Assignee
Smithkline Beecham Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp. filed Critical Smithkline Beecham Corp.
Publication of HUP0301130A2 publication Critical patent/HUP0301130A2/en
Publication of HUP0301130A3 publication Critical patent/HUP0301130A3/en

Links

Classifications

    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00—Formation of filaments, threads, or the like
    • D01D5/0007—Electro-spinning
    • D01D5/0015—Electro-spinning characterised by the initial state of the material
    • D01D5/003—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
    • D01D5/0038—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion the fibre formed by solvent evaporation, i.e. dry electro-spinning
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00—Formation of filaments, threads, or the like
    • D01D5/0007—Electro-spinning
    • D01D5/0015—Electro-spinning characterised by the initial state of the material
    • D01D5/0023—Electro-spinning characterised by the initial state of the material the material being a polymer melt
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F1/00—General methods for the manufacture of artificial filaments or the like
    • D01F1/02—Addition of substances to the spinning solution or to the melt
    • D01F1/10—Other agents for modifying properties

Abstract

A tömegarány egy mérsékelten vízoldható vagy vízben oldhatatlan,gyógyszerészetileg elfogadható hatóanyaggal integráltgyógyszerészetileg elfogadható polimer hordozó elektrofonott szálaibólálló gyógyszerkészítményre vonatkozik. A találmány kiterjed agyógyszerkészítmények oldatból vagy olvadékból végzettelektrosztatikus fonással történő előállítási eljárásaira is. ÓThe weight ratio refers to a pharmaceutical preparation consisting of electrospun fibers of a moderately water-soluble or water-insoluble, pharmaceutically acceptable active ingredient integrated with a pharmaceutically acceptable polymer carrier. The invention also covers the production processes of pharmaceutical preparations from solutions or melts by electrostatic spinning. HE

HU0301130A 2000-01-28 2001-01-25 Electrospun pharmaceutical compositions HUP0301130A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17868200P 2000-01-28 2000-01-28
PCT/US2001/002399 WO2001054667A1 (en) 2000-01-28 2001-01-25 Electrospun pharmaceutical compositions

Publications (2)

Publication Number Publication Date
HUP0301130A2 true HUP0301130A2 (en) 2003-09-29
HUP0301130A3 HUP0301130A3 (en) 2006-07-28

Family

ID=22653497

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0301130A HUP0301130A3 (en) 2000-01-28 2001-01-25 Electrospun pharmaceutical compositions

Country Status (18)

Country Link
EP (1) EP1251829A4 (en)
JP (1) JP2003521493A (en)
KR (1) KR100806412B1 (en)
CN (1) CN1223340C (en)
AR (1) AR028204A1 (en)
AU (1) AU772830B2 (en)
BR (1) BR0107869A (en)
CA (1) CA2396640A1 (en)
HU (1) HUP0301130A3 (en)
IL (1) IL150642A0 (en)
MX (1) MXPA02007298A (en)
MY (1) MY129356A (en)
NO (1) NO20023338L (en)
NZ (1) NZ519992A (en)
PL (1) PL356924A1 (en)
TW (1) TWI289061B (en)
WO (1) WO2001054667A1 (en)
ZA (1) ZA200205989B (en)

Families Citing this family (116)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9910505D0 (en) 1999-05-06 1999-07-07 Electrosols Ltd A method and apparatus for manufacturing consumable tablets
AU2438702A (en) * 2000-10-18 2002-04-29 Univ Virginia Commonwealth Electroprocessing in drug delivery and cell encapsulation
EP1982735A1 (en) * 2000-11-17 2008-10-22 Virginia Commonwealth University Intellectual Property Foundation Electroprocessed collagen
JP2010163435A (en) * 2000-11-17 2010-07-29 Virginia Commonwealth Univ Intellectual Property Foundation Electroprocessed collagen
EP1377421A4 (en) * 2001-03-20 2004-05-26 Nicast Ltd Polymer fiber tubular structure having improved kinking resistance
US6685956B2 (en) * 2001-05-16 2004-02-03 The Research Foundation At State University Of New York Biodegradable and/or bioabsorbable fibrous articles and methods for using the articles for medical applications
GB0123951D0 (en) * 2001-10-05 2001-11-28 Glaxo Group Ltd Therapies for treating respiratory diseases
CA2474838C (en) 2002-02-01 2009-01-06 Pfizer Products Inc. Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials
KR100549140B1 (en) * 2002-03-26 2006-02-03 이 아이 듀폰 디 네모아 앤드 캄파니 A electro-blown spinning process of preparing for the nanofiber web
BRPI0309022A2 (en) 2002-04-04 2016-11-08 Univ Akron nonwoven fiber sets
US8367570B2 (en) 2002-04-04 2013-02-05 The University Of Akron Mechanically strong absorbent non-woven fibrous mats
AU2003221677A1 (en) * 2002-04-11 2003-10-27 Secant Medical, Inc. Covering process using electrospinning of very small fibers
US20060083784A1 (en) * 2002-08-07 2006-04-20 Smithkline Beecham Corporation Amorphous pharmaceutical compositions
TW200410714A (en) * 2002-08-07 2004-07-01 Smithkline Beecham Corp Electrospun amorphous pharmaceutical compositions
US7842780B2 (en) 2003-01-07 2010-11-30 Trustees Of Tufts College Silk fibroin materials and use thereof
ATE540671T1 (en) 2003-08-04 2012-01-15 Bend Res Inc PHARMACEUTICAL COMPOSITIONS OF AMORPHOUS DRUG ADSORBATES AND LIPOPHILIC MICROPHASE-FORMING MATERIALS
WO2005065657A2 (en) 2003-12-31 2005-07-21 Pfizer Products Inc. Solid compositions of low-solubility drugs and poloxamers
JP4526851B2 (en) * 2004-03-31 2010-08-18 明彦 谷岡 Polysaccharide nanoscale fibers and compacts
WO2006006746A1 (en) * 2004-07-09 2006-01-19 Hak-Yong Kim Polymer particles, and a method for manufacturing the same
CN100577720C (en) * 2005-03-21 2010-01-06 中国科学院化学研究所 Biodegradable and absorb polymer nano fibrous membrane materials and method for making and purposes
JP2006299459A (en) * 2005-04-20 2006-11-02 National Institute For Materials Science Method for producing biodegradable polymer nonwoven fabric tube
CN1300393C (en) * 2005-07-01 2007-02-14 中国科学院长春应用化学研究所 Preparation method of ultrafine fiber medical agent type emulsion electro spinning fiber
JP5339328B2 (en) * 2005-07-21 2013-11-13 独立行政法人物質・材料研究機構 Drug inhalation device
JP4787585B2 (en) * 2005-09-29 2011-10-05 帝人株式会社 Manufacturing method of fiber structure by electrostatic spinning method
CN100556399C (en) * 2005-12-23 2009-11-04 中国科学院广州化学研究所 A kind of intestine target medicinal controlled release fiber and preparation method thereof
US8367112B2 (en) 2006-02-28 2013-02-05 Alkermes Pharma Ireland Limited Nanoparticulate carverdilol formulations
KR100824719B1 (en) * 2006-09-04 2008-04-24 주식회사 아모메디 Bio-degradable food-packing materials consisting of starch-contained nonwoven-nanofabrics and preparation methods therefor
US9233080B2 (en) * 2008-03-27 2016-01-12 Agigma, Inc. Compositions and methods for the delivery of agents
EP2666457B1 (en) 2008-04-16 2020-06-17 The Procter & Gamble Company Process for forming a non-lathering personal care article in the form of a dissolvable solid foam
JP2011530491A (en) 2008-08-08 2011-12-22 ビーエーエスエフ ソシエタス・ヨーロピア Biopolymer-based continuous fiber layers containing active substances, their use, and methods for their production
US20110129510A1 (en) 2008-08-08 2011-06-02 Basf Se Fibrous surface structure containing active ingredients with controlled release of active ingredients, use thereof and method for the production thereof
CN101721751B (en) * 2008-10-10 2013-01-02 张阳德 Human tissue engineering support loaded with controlled-release cell growth factor and provided with hollow silicon dioxide ball with kernel and preparation method and applications thereof
US20100291182A1 (en) * 2009-01-21 2010-11-18 Arsenal Medical, Inc. Drug-Loaded Fibers
KR101065255B1 (en) * 2009-02-13 2011-09-16 김근형 New drug delivery system using electrospinning of biodegradable polymers
CN101559242B (en) * 2009-05-22 2015-07-29 广州迈普再生医学科技有限公司 A kind of can simultaneously as the nano artificial cerebral dura mater and preparation method thereof of drug controlled release system
WO2011029777A1 (en) 2009-09-11 2011-03-17 Basf Se Methods for producing coated polymer fibers
EP2509564B1 (en) 2009-12-08 2013-11-20 The Procter and Gamble Company A porous, dissolvable solid substrate and surface resident coating comprising matrix microspheres
WO2011103152A1 (en) 2010-02-16 2011-08-25 The Procter & Gamble Company A porous, dissolvable solid substrate and surface resident coating comprising a zync pyrithione
CN101816627B (en) * 2010-04-16 2012-03-07 浙江大学 Synergistic treatment type multi-material sustained-release eye drop and preparation method
BR112012033600A2 (en) 2010-07-02 2016-11-29 Procter & Gamble Comapny filaments comprising ingestible nonwoven webs and methods of manufacturing them.
JP5859526B2 (en) 2010-07-02 2016-02-10 ザ プロクター アンド ギャンブルカンパニー Filaments containing an activator nonwoven web and methods for making the same
US20180163325A1 (en) 2016-12-09 2018-06-14 Robert Wayne Glenn, Jr. Dissolvable fibrous web structure article comprising active agents
RU2543892C2 (en) 2010-07-02 2015-03-10 Дзе Проктер Энд Гэмбл Компани Production of films from nonwoven webs
WO2012003367A2 (en) 2010-07-02 2012-01-05 The Procter & Gamble Company Method for delivering an active agent
CA2803377C (en) 2010-07-02 2018-03-20 The Procter & Gamble Company Methods of delivering a health care active by administering personal health care articles comprising a filament
WO2012003300A2 (en) * 2010-07-02 2012-01-05 The Procter & Gamble Company Filaments comprising a non-perfume active agent nonwoven webs and methods for making same
CN103003476B (en) 2010-07-02 2016-02-10 宝洁公司 Web material and the method for the manufacture of web material
JP6113072B2 (en) 2010-07-02 2017-04-12 ザ プロクター アンド ギャンブル カンパニー Method for manufacturing personal care article
CN101915797B (en) * 2010-07-27 2011-09-28 北京师范大学 Method for preparing electrostatic spinning immobilized laccase electrode
US9808418B2 (en) 2010-11-26 2017-11-07 University Of The Witwatersrand, Johannesburg Pharmaceutical dosage form
WO2012084441A1 (en) 2010-12-22 2012-06-28 Unilever Nv Compositions in the form of fibres
WO2012084427A1 (en) 2010-12-22 2012-06-28 Unilever Nv Compositions comprising structured non-aqueous liquid phase
CZ303244B6 (en) 2011-01-17 2012-06-13 Elmarco S.R.O. Carrier for oromucosal, especially sublingual application of physiologically active compounds
CN102251317B (en) * 2011-05-18 2013-01-16 东华大学 Preparation method of electrospun fibers with controllable drug release
WO2013124869A2 (en) * 2012-02-21 2013-08-29 Amrita Vishwa Vidyapeetham University The art, method,manner process and system of fibrous bio-degradable polymeric wafers for the local delivery of therapeutic agents in combinations
CN102631715A (en) * 2012-05-04 2012-08-15 江南大学 Preparation method of anti-coagulation nano fiber membrane
CN102670483B (en) * 2012-05-09 2014-04-02 上海交通大学 Electrostatic spinning fiber membrane preparation for treating hyperlipidemia and preparation method thereof
CN102697727B (en) * 2012-06-12 2014-01-08 东华大学 Method for preparing self-assembly ketoprofen liposome by electrostatic spinning technology
KR101454360B1 (en) 2012-08-31 2014-10-24 서울대학교산학협력단 A gelatin nanofibrous web containing Phaeodactylum triconutum extracts and wound dressing using the same
US11896693B2 (en) 2019-12-01 2024-02-13 The Procter & Gamble Company Hair conditioner compositions with a preservative system containing sodium benzoate and glycols and/or glyceryl esters
CN104884037B (en) 2012-10-12 2018-02-16 宝洁公司 The personal care composition of soluble preparation form
CZ308409B6 (en) * 2013-02-26 2020-08-05 Elmarco S.R.O. Preparation for the administration of at least one biologically and / or pharmaceutically active substance
WO2014142675A1 (en) 2013-03-12 2014-09-18 Active Fibres Limited Nanofibre and bioactive compositions and related methods
EP2813212A1 (en) 2013-06-10 2014-12-17 Zentiva, a.s. Drug formulation using API in nanofibers
US10202636B2 (en) 2013-12-24 2019-02-12 General Electric Company Electrospun fibers for protein stabilization and storage
CN106413683A (en) 2014-04-22 2017-02-15 宝洁公司 Compositions in the form of dissolvable solid structures
US9937111B2 (en) 2014-05-05 2018-04-10 The Procter & Gamble Company Consumer product comprising a fibrous web solid structure with a silicone conditioning agent coating
US9861558B2 (en) 2014-05-05 2018-01-09 The Procter & Gamble Company Methods of forming an aqueous treatment liquor by dissolving a porous solid with a benefit agent coating
US9861559B2 (en) 2014-05-05 2018-01-09 The Procter & Gamble Company Consumer product comprising a porous, dissolvable, fibrous web solid structure with a silicone coating
US9877899B2 (en) 2014-05-05 2018-01-30 The Procter & Gamble Company Consumer product comprising a fibrous web structure with a silicone conditioning agent coating
US9827173B2 (en) 2014-05-05 2017-11-28 The Procter & Gamble Company Porous dissolvable solid structure with two benefit agents and methods of forming an aqueous treatment liquor therefrom
US9867762B2 (en) 2014-05-05 2018-01-16 The Procter & Gamble Company Consumer product comprising a porous dissolvable solid structure and silicone conditioning agent coating
MX2016015688A (en) * 2014-06-10 2017-05-30 Dermtreat Aps Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa.
CN105362269A (en) * 2014-09-01 2016-03-02 天津药物研究院 Saccharose containing roflumilast tablets and preparation method thereof
EP3278791A4 (en) * 2015-03-31 2018-10-24 Orthorebirth Co., Ltd. Method for manufacturing drug-containing biodegradable fiber material by electrospinning
BR112018000399A2 (en) * 2015-07-07 2018-09-11 Nat Univ Singapore method for preparing a polymeric product, polymeric product, polymeric cell or tissue culture product and polymeric coating solution
CN105327357B (en) * 2015-10-14 2019-01-11 北京科技大学 A kind of drug-loading system of hyaluronic acid and preparation method thereof of catechol modification
AU2016358266B2 (en) * 2015-11-19 2018-06-21 Afyx Therapeutics A/S A pharmaceutical composition comprising electrohydrodynamically obtained fibres, the composition having improved residence time on the application site
AU2017211684B2 (en) * 2016-01-27 2022-10-06 Instar Technologies A.S. Oromucosal nanofiber carriers for therapeutic treatment
CN105727358B (en) * 2016-02-23 2019-01-22 广西易得佳医疗器械有限公司 Drug-loaded biological high-molecular composite nanometer tunica fibrosa and preparation method thereof
CN105663025A (en) * 2016-02-29 2016-06-15 浙江工业大学 Drug-containing microfilament and preparation method thereof
WO2018133910A1 (en) 2017-01-23 2018-07-26 Dermtreat Aps Method for preparing electrospun fibers with a high content of a bioadhesive substance
RU2019125715A (en) 2017-01-23 2021-02-24 Афикс Терапьютикс А/С METHOD FOR PRODUCING TWO-LAYER PRODUCT BASED ON ELECTRICALLY SPOTTED FIBERS
WO2018140675A1 (en) 2017-01-27 2018-08-02 The Procter & Gamble Company Compositions in the form of dissolvable solid structures comprising effervescent agglomerated particles
EP3573593B1 (en) 2017-01-27 2023-08-30 The Procter & Gamble Company Compositions in the form of dissolvable solid structures
JP6923673B2 (en) 2017-05-16 2021-08-25 ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ Conditioning hair care compositions in the form of soluble solid structures
CN107447366A (en) * 2017-08-03 2017-12-08 东华大学 A kind of sensitive medicament-carried sustained release nano fiber films of pH and its preparation method and application
KR20200085891A (en) 2018-01-26 2020-07-15 더 프록터 앤드 갬블 캄파니 Water soluble unit dose article containing fragrance
KR20200086739A (en) 2018-01-26 2020-07-17 더 프록터 앤드 갬블 캄파니 Water soluble unit dose article containing enzyme
KR102433420B1 (en) 2018-01-26 2022-08-18 더 프록터 앤드 갬블 캄파니 Water-Soluble Articles and Related Methods
WO2019147532A1 (en) 2018-01-26 2019-08-01 The Procter & Gamble Company Water-soluble unit dose articles comprising perfume
WO2019168829A1 (en) 2018-02-27 2019-09-06 The Procter & Gamble Company A consumer product comprising a flat package containing unit dose articles
JP7121944B2 (en) * 2018-05-07 2022-08-19 国立大学法人信州大学 Nanofiber and its manufacturing method
JP1639110S (en) 2018-07-16 2019-08-13
US10982176B2 (en) 2018-07-27 2021-04-20 The Procter & Gamble Company Process of laundering fabrics using a water-soluble unit dose article
US11666514B2 (en) 2018-09-21 2023-06-06 The Procter & Gamble Company Fibrous structures containing polymer matrix particles with perfume ingredients
US11859338B2 (en) 2019-01-28 2024-01-02 The Procter & Gamble Company Recyclable, renewable, or biodegradable package
EP3712237A1 (en) 2019-03-19 2020-09-23 The Procter & Gamble Company Fibrous water-soluble unit dose articles comprising water-soluble fibrous structures
JP7381613B2 (en) 2019-06-28 2023-11-15 ザ プロクター アンド ギャンブル カンパニー Dissolvable solid fibrous article containing anionic surfactant
CN114025738A (en) 2019-07-03 2022-02-08 宝洁公司 Fibrous structures comprising cationic surfactants and soluble acids
USD939359S1 (en) 2019-10-01 2021-12-28 The Procter And Gamble Plaza Packaging for a single dose personal care product
MX2022002875A (en) 2019-10-14 2022-03-25 Procter & Gamble Biodegradable and/or home compostable sachet containing a solid article.
MX2022003979A (en) 2019-11-20 2022-04-26 Procter & Gamble Porous dissolvable solid structure.
USD962050S1 (en) 2020-03-20 2022-08-30 The Procter And Gamble Company Primary package for a solid, single dose beauty care composition
USD941051S1 (en) 2020-03-20 2022-01-18 The Procter And Gamble Company Shower hanger
USD965440S1 (en) 2020-06-29 2022-10-04 The Procter And Gamble Company Package
MX2023001042A (en) 2020-07-31 2023-02-16 Procter & Gamble Water-soluble fibrous pouch containing prills for hair care.
EP4196235A1 (en) 2020-08-11 2023-06-21 The Procter & Gamble Company Low viscosity hair conditioner compositions containing brassicyl valinate esylate
MX2023001043A (en) 2020-08-11 2023-02-16 Procter & Gamble Clean rinse hair conditioner compositions containing brassicyl valinate esylate.
CN116018123A (en) 2020-08-11 2023-04-25 宝洁公司 Moisturizing hair conditioner composition containing valine ester ethane sulfonate of brassinolide
WO2022119783A1 (en) 2020-12-01 2022-06-09 The Procter & Gamble Company Aqueous hair conditioner compositions containing solubilized anti-dandruff actives
CN113041230B (en) * 2021-03-23 2022-06-24 浙江尖峰健康科技有限公司 Capsule shell of soft capsule and soft capsule prepared from capsule shell
KR102653460B1 (en) * 2021-09-01 2024-03-29 한남대학교 산학협력단 A method for manufacturing starch nanofiber comprising collagen and lecithin with controlled degradability
WO2023145886A1 (en) * 2022-01-31 2023-08-03 三菱ケミカル株式会社 Nanofibers
CN114808184A (en) * 2022-03-11 2022-07-29 深圳市法鑫忠信新材料有限公司 Long-acting mosquito-repelling electrostatic spinning fiber and preparation method and application thereof
CN115887422A (en) * 2022-12-31 2023-04-04 兰州交通大学 Lappaconitine knee bone joint pain-relieving sustained-release patch and preparation method thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1527592A (en) * 1974-08-05 1978-10-04 Ici Ltd Wound dressing
US4855326A (en) * 1987-04-20 1989-08-08 Fuisz Pharmaceutical Ltd. Rapidly dissoluble medicinal dosage unit and method of manufacture
US5567439A (en) * 1994-06-14 1996-10-22 Fuisz Technologies Ltd. Delivery of controlled-release systems(s)
US5736152A (en) * 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
US5869098A (en) * 1997-08-20 1999-02-09 Fuisz Technologies Ltd. Fast-dissolving comestible units formed under high-speed/high-pressure conditions
US5980941A (en) * 1997-08-20 1999-11-09 Fuisz Technologies Ltd. Self-binding shearform compositions
US6753454B1 (en) * 1999-10-08 2004-06-22 The University Of Akron Electrospun fibers and an apparatus therefor

Also Published As

Publication number Publication date
CN1223340C (en) 2005-10-19
CA2396640A1 (en) 2001-08-02
IL150642A0 (en) 2003-02-12
NO20023338L (en) 2002-09-03
AU3113401A (en) 2001-08-07
NZ519992A (en) 2004-04-30
EP1251829A1 (en) 2002-10-30
NO20023338D0 (en) 2002-07-11
KR20020082212A (en) 2002-10-30
AR028204A1 (en) 2003-04-30
AU772830B2 (en) 2004-05-06
MY129356A (en) 2007-03-30
HUP0301130A3 (en) 2006-07-28
EP1251829A4 (en) 2009-05-06
PL356924A1 (en) 2004-07-12
TWI289061B (en) 2007-11-01
WO2001054667A1 (en) 2001-08-02
KR100806412B1 (en) 2008-02-21
ZA200205989B (en) 2003-02-03
MXPA02007298A (en) 2002-12-09
BR0107869A (en) 2002-11-05
JP2003521493A (en) 2003-07-15
CN1396823A (en) 2003-02-12

Similar Documents

Publication Publication Date Title
HUP0301130A2 (en) Electrospun pharmaceutical compositions
WO2004014304A3 (en) Electrospun amorphous pharmaceutical compositions
NO20025621D0 (en) Sustained release pharmaceutical composition for parenteral administration of hydrophilic compounds
WO2003070749A3 (en) Self-assembly of peptide-amphiphile nanofibers under physiological conditions
FR2805817B1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING AZETIDINE DERIVATIVES, NOVEL AZETIDINE DERIVATIVES AND THEIR PREPARATION
WO2001032632A3 (en) Pharmaceutically active 4-substituted pyrimidine derivatives
BR0109200A (en) Compounds, process for preparing compounds, pharmaceutical compositions, and process for manufacturing same
FR2757521B1 (en) NOVEL CYCLOSPORIN DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
WO2001096334A3 (en) Heteroarylalkanoic acids as integrin receptor antagonists
ATE387430T1 (en) COMPOUNDS AND COMPOSITIONS FOR DELIVERING ACTIVE INGREDIENTS
NO20011721D0 (en) N-aralkylaminotetralins as ligands for neuropeptide Y Y5 receptor
FR2762843B1 (en) NOVEL CYCLOSPORIN DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2757522B1 (en) CYCLOSPORIN DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
NO20062051L (en) Pharmaceutical active ingredient-containing formulation with coating
ATE407128T1 (en) PHENYL-SUBSTITUTED 5,6-DIHYDRO-PYRONE DERIVATIVES AS PESTICIDES AND HERBICIDES
FR2764889B1 (en) NOVEL 2- (IMINOMETHYL) AMINO-PHENYL DERIVATIVES, THEIR PREPARATION, THEIR USE AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
HUP0102515A2 (en) Cyclopeptides, process for their preparation, pharmaceutical compositions comprising thereof and their use
WO2002015959A3 (en) Compounds and compositions for delivering active agents
GEP20053617B (en) Bridged Piperazine Derivatives
HUP0500842A2 (en) Pharmaceutical dronedarone composition for parenteral administration
ATE286894T1 (en) 2H-1-BENZOPYRAN DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS
WO2001056992A3 (en) Dibenzo (b,f) azepine intermediates
WO2008122994A3 (en) Stable pharmaceutical compositions of clopidogrel bisulfate and process of preparation thereof
WO2003031467A3 (en) Amino-substituted camptothecin polymer derivatives and use of the same for the manufacture of a medicament
WO2004069187A3 (en) Drug formulation and delivery using crystalline methylated cyclodextrins

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees